StockWatch
·
Biotechnology: Pharmaceutical Preparations
BuybackAug 4, 2026, 10:48 AM

Novo Nordisk Share Buyback Update: DKK 7.53B Repurchased

AI Summary

Novo Nordisk provided an update on its ongoing share repurchase program. As of August 3, 2026, the company has repurchased a total of DKK 7,533,256,457 worth of B shares since February 4, 2026, as part of its overall DKK 15 billion program. Under a specific program initiated on May 6, 2026, the company has repurchased 12,305,000 B shares for DKK 3,733,256,468. Novo Nordisk now holds 1.0% of its share capital as treasury shares.

Key Highlights

  • Overall share repurchase program up to DKK 15 billion, started Feb 4, 2026.
  • Specific program initiated May 6, 2026, for up to DKK 11.2 billion.
  • Accumulated DKK 3,733,256,468 repurchased under specific program as of Aug 3, 2026.
  • Total 12,305,000 B shares repurchased under specific program.
  • Total DKK 7,533,256,457 repurchased since Feb 4, 2026.
  • Company owns 44,249,480 treasury B shares, representing 1.0% of share capital.